Day: November 14, 2022

CommonWealth Parenting Combines Education with the Metaverse during the 2022 International Conference on Education Innovation APhoto.JPG

TAIPEI, TAIWAN – Media OutReach – 14 November 2022 – Taiwan’s seminal education-related extravaganza, the “International Conference on Education Innovation” hosted by CommonWealth Education Media and Publishing (CommonWealth Parenting), recently concluded its eleventh iteration. The central theme of 2022 was “Better”. Over 30 educational leaders from Taiwan, Japan, and the United States shared their views […]

Nuance Pharma Announces Clearance of IND Application for Respiratory Syncytial Virus (RSV) Vaccine in China

SHANGHAI, Nov. 14, 2022 /PRNewswire/ — Nuance Pharma (“the Company”) announces the Center for Drug Evaluation (“CDE”) has approved its Investigational New Drug (“IND”) application supporting its pivotal phase III clinical trial of MVA-BN RSV vaccine against respiratory syncytial virus (RSV) in adults in mainland China. MVA-BN RSV, is being developed for the prevention of respiratory […]

Charting holistic development in the fields of business and accountancy through the inaugural Crowe ScholarshipCrowe-Logo.jpg

SINGAPORE – Media OutReach – 14 November 2022 – Crowe Singapore (“Crowe”) has awarded two Ngee Ann Polytechnic students with its inaugural Crowe Scholarship, which aims to motivate outstanding students to make an impact in the society and the fields of business and accountancy. Newly minted Crowe Scholars, Mr Jonathan Chaw Junxi and Ms Kelly […]

Lifebuoy and Doctor Anywhere Announce a Strategic Partnership to Help Advance Singapore’s Preventive Healthcare StrategyIMG-6379.jpg

SINGAPORE – Media OutReach – 14 November 2022 – Lifebuoy, the world’s number one hygiene soap brand1, entered an official partnership today with Doctor Anywhere (DA), a regional omnichannel health provider, aiming to educate, engage, and enable one million Singaporeans to improve their health proactively. The ceremony was held at @one-north Unilever campus, the APAC […]


New campus combines R&D, manufacturing, and training with the latest state-of-art facilities Brings innovation to next-level integration with medical professionals Expected to reach industrial-scale production levels with an output value of over 10 billion RMB (approximately US$1.38 billion) in three to five years   SINGAPORE, Nov. 14, 2022 /PRNewswire/ — Genesis MedTech Group (Genesis MedTech […]

Making Debut at Doha International Airport, Chery Shares a Football Feast with You

CANBERRA, Australia, Nov. 14, 2022 /PRNewswire/ — As the football feast in Qatar approaches, the relevant elements have already spread throughout the streets and lanes of Qatar’s major cities. At Doha International Airport, Chery makes a prominent appearance for facilitating this football event, allowing every arriving passenger to get into the carnival rhythm in advance. According […]

SK Biopharmaceuticals Receives Korea Drug Development Fund Investment Grant to Develop Novel Oncology Candidate, SKL27969

State-run financing to provide two-year support of Phase 1 research for oncology candidate, SKL27969, for the potential treatment of advanced solid tumors SK Biopharmaceuticals to present preclinical data on oncology candidate, SKL27969, at Society for Neuro-Oncology Conference PANGYO, South Korea, Nov. 14, 2022 /PRNewswire/ — SK Biopharmaceuticals, a global innovative pharmaceutical company, announced that the […]

Akeso’s Ivonescimab (PD-1/VEGF Bispecific Antibody, AK112) Granted Breakthrough Therapy Designation for I-O Resistance NSCLC Patients in China

AK112 has now been granted three Breakthrough Therapy Designations for NSCLC The only drug candidate granted Breakthrough Therapy Designation for I-O Resistance NSCLC in China HONG KONG, Nov. 14, 2022 /PRNewswire/ — Akeso, Biopharma (9926. HK) (“Akeso”) announced that the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA) has granted […]

Back To Top